KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to -$53.5 million.

  • Dynavax Technologies' Net Cash Flow rose 843.05% to $61.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.3 million, marking a year-over-year increase of 212.72%. This contributed to the annual value of -$53.5 million for FY2024, which is 3.00% down from last year.
  • Dynavax Technologies' Net Cash Flow amounted to -$53.5 million in FY2024, which was down 3.00% from -$52.0 million recorded in FY2023.
  • Dynavax Technologies' 5-year Net Cash Flow high stood at $405.5 million for FY2021, and its period low was -$233.8 million during FY2022.
  • Its 3-year average for Net Cash Flow is -$113.1 million, with a median of -$53.5 million in 2024.
  • As far as peak fluctuations go, Dynavax Technologies' Net Cash Flow skyrocketed by 4,468.04% in 2021, and later tumbled by 157.64% in 2022.
  • Yearly analysis of 5 years shows Dynavax Technologies' Net Cash Flow stood at -$9.3 million in 2020, then surged by 4,468.04% to $405.5 million in 2021, then crashed by 157.64% to -$233.8 million in 2022, then spiked by 77.76% to -$52.0 million in 2023, then dropped by 3.00% to -$53.5 million in 2024.